EUVIMEDEUVIMED entdecken
Systematische Übersicht

Antiplasmodial potential of Lansium domesticum Corrêa: A systematic review and critical appraisal of preclinical evidence

Fanny Fanny, Salwa Adilah Ningtiyas, Sadakata Sinulingga

Magna Scientia Advanced Research and Reviews · 31.08.2026 · 17 (2) · 430-433

DOI: 10.30574/msarr.2026.17.2.0147 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Magna Scientia Advanced Research and Reviews, online erschienen am 31.08.2026. Verfasst von Fanny Fanny und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although Lansium domesticum Corrêa is widely used in Southeast Asian traditional medicine, its phytochemical diversity and antioxidant activity cannot be considered definitive evidence of antimalarial efficacy. A rigorous synthesis is required to distinguish specific anti-parasitic findings from data that only informs chemical characteristics or host-cell safety.

Objective

This review aims to critically synthesize 17 species-specific primary studies published between 2016 and 2026 to differentiate direct antiplasmodial evidence from translational-enabling data.

Methods

This systematic review was prospectively registered in PROSPERO (CRD420261458422). Systematic searches through July 2026 targeted studies reporting malaria-related endpoints. Evidence was classified as direct (whole-parasite assays, infected-animal models, or parasite-specific targets) or translational-enabling (phytochemical characterization, safety, or mechanistic evidence). Findings were synthesized narratively in accordance with the PRISMA 2020 statement and the Synthesis Without Meta-analysis (SWiM) reporting guideline.

Results

Seventeen studies were identified: four provided direct evidence and 13 were enabling. Root chloroform and methanol fractions exhibited potent in vitro inhibition (IC50 1.4–3.6 µg/mL), yet in vivo stem-bark data showed a non-monotonic response and a high risk of bias. A significant unit discrepancy (mg/mL vs. µg/mL) was identified in reports for dukunolides, and in silico docking results lack experimental confirmation. Currently, no lead candidate possesses matched parasite-host selectivity, standardized chemistry, or pharmacokinetic data.

Conclusion

Lansium domesticum is currently a source of preclinical leads rather than a validated antimalarial medicine. Future research must prioritize unit verification, standardized same-batch selectivity testing, mechanism validation, and rigorously controlled animal studies.

Zitieren

APA

Fanny, F., Ningtiyas, S. A., & Sinulingga, S. (2026). Antiplasmodial potential of Lansium domesticum Corrêa: A systematic review and critical appraisal of preclinical evidence. Magna Scientia Advanced Research and Reviews, 17(2), 430-433. https://doi.org/10.30574/msarr.2026.17.2.0147

Vancouver

Fanny F, Ningtiyas SA, Sinulingga S. Antiplasmodial potential of Lansium domesticum Corrêa: A systematic review and critical appraisal of preclinical evidence. Magna Scientia Advanced Research and Reviews. 2026;17(2):430-433. doi:10.30574/msarr.2026.17.2.0147

BibTeX
@article{Fanny2026,
  author = {Fanny, Fanny and Ningtiyas, Salwa Adilah and Sinulingga, Sadakata},
  title = {Antiplasmodial potential of Lansium domesticum Corrêa: A systematic review and critical appraisal of preclinical evidence},
  journal = {Magna Scientia Advanced Research and Reviews},
  year = {2026},
  volume = {17},
  number = {2},
  pages = {430--433},
  doi = {10.30574/msarr.2026.17.2.0147}
}
Kostenlos starten →